AZTR Azitra, Inc.

$0.61

Azitra, Inc. (AZTR) is expected to report earnings on February 11, 2027, after the market close. The consensus earnings estimate is a loss of $0.25 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -7.9% since its last earnings release on November 12, 2026.

Azitra Missed Consensus Estimates
Thursday, November 12, 2026 · 4:30 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · 5:00 PM ET
Earnings Whisper
-
vs ($0.25)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.62

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Azitra, Inc.

Azitra Inc. is an early-stage clinical biopharmaceutical company. It focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. Azitra Inc. is based in BRANFORD, Conn.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.